SlideShare a Scribd company logo
MARKET ACCESS:
DEPARTMENT
MODELS AND
STRUCTURES
N O V E M B E R , 2 0 1 5
P R E V I E W O F
marketaccess
REPORT OVERVIEW
WHAT YOU WILL LEARN
How you can use this report
ISR interviewed 14 highly experienced decision-
makers to better understand the Market Access
function. These professionals shared their
perspectives on a range of topics related to the Market
Access function, including the role of Market Access
within their organizations, the structure of the Market
Access function, and the key challenges faced by
Market Access. Where possible, ISR also collected
information on departmental headcounts, budgets,
and outsourcing volume.
54
PAGES
19
POTENTIAL
BEST PRACTICES
CAPTURED
INTERVIEWEE TITLES
MAJOR
SECTIONS:
1.	 Introduction
2.	 Market Access Employees
3.	 Market Access Goals and
Priorities
4.	 Market Access Structure
5.	 Organizational Alignment
6.	 Outsourcing Behavior
7.	 Market Access Budget
8.	 Challenges
9.	 Future Predictions
10.	Best Practices and
Recommendations
•	 Market Access department operations and structuring, including:
•	 Division of work for both global and regional Market Access
•	 Common department structure and unique department structures within
companies
•	 Organizational alignment and comparison of Market Access placement
•	 Outsourcing behavior: services outsourced, vendor selection, reasons
for outsourcing
•	 Future predictions for the department
•	 Sources of Market Access budget, including factors that impact budget and
sources of funding
•	 Market Access goals and priorities, including strategies for overcoming
challenges and predictions for future changes
•	 Best practices for: Market Access budget and challenges, timing of Market
Access involvement, outsourcing behaviors, department structure and
function
•	 Determine where your company’s approach to Market Access may be different
from a typical industry approach and the benefits and drawbacks that may result.
•	 Gather information on unique Market Access structures or philosophies
employed by other organizations to provide a new perspective from which to
consider your company’s philosophies.
•	 Compare your company’s approach to the size the Market Access function and
budget against those of other companies.
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
•	 Head, Global Market Access	
•	 Head, Global Pricing and Market Access
•	 Senior Director, Global Market Access	
•	 Senior Director, Market Access
•	 Director, Global Market Access
•	 Director, Market Access
•	 Director, Market Access and Health Economics
•	 Director, Market Access Strategy
•	 Director, Pricing and Reimbursement
•	 Associate Director, Global Pricing and Market Access
•	 Associate Director, Reimbursement and Market Access
•	 Senior Manager, Market Access
D A T A
C O L L E C T I O N
I N Q 3 , 2 0 1 5
6 0 - M I N U T E
T E L E P H O N E
I N T E R V I E W S
1 4
E X P E R I E N C E D
M A R K E T A C C E S S
P R O F E S S I O N A L S
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
TABLE OF CONTENTS
To view the Table of Contents, download the full preview from:
www.isrreports.com/reports/market-access-department-models-and-structures/
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
UNDERSTANDING THE MARKET ACCESS FUNCTION
Market Access: Department models and structures 12www.ISRreports.com ©2015
Though the desired skillsets vary according to the specific role, interviewees described a number
of qualities that are critical to success in any Market Access role�
Communication is considered one of the core skills required for success in Market Access� The
role requires interaction and engagement with a range of colleagues internally as well as with
reimbursement and payer bodies externally� The global Market Access role was described as a
bridge between the Clinical Development and Commercial functions�
Influencing skills are also critical� Interviewees commented that the role could
be viewed as “the harbinger of bad news” within a multidisciplinary team as
their input can be seen to increase workload and expense of clinical trials and
commercialization plans� It is therefore important to be able to influence
decision-making in a way that is considered thoughtful, incisive, and from a
position of knowledge and experience.
Networking skills are essential as the role requires an “ability to reach across the aisle and work
with all of the different functions� This requires an individual who can influence without a direct
reporting line, engage, and align” (Top 10 Pharma)� The highly matrixed environment of Market
Access means that there are many reporting lines and thereby many different priorities which
must be successfully managed to meet timelines� For local Market Access roles, networking is
required to maintain contacts within other countries as well as their own regions.
OYEE QUALITIES
SCIENTIFIC
KNOWLEDGE
EXPERT
KNOWLEDGE
COMMUNICATION
STRATEGIC AGILITY
LEADERSHIP
RELATIONSHIP
BUILDING
TECHNICAL SKILLS
NETWORKING
INFLUENCING
MARKET
ACCESS
EMPLOYEE
S A M P L E P A G E :
MARKET ACCESS
EMPLOYEE
QUALITIES
Communication is considered
one of the core skills required
for success in Market Access.
The role requires interaction
and engagement with a range of
colleagues internally as well as
with reimbursement and payer
bodies externally. The global
Market Access role was described
as a bridge between the Clinical
Development and Commercial
functions.
C L O S E R L O O K
>>This chart shows a
number of qualities that
are necessary to be
successful in the Market
Access role.
Introduction
SECTION NAME
Though the desired skillsets vary according to the specific role, interviewees described a number of
qualities that are critical to success in any Market Access role�
EMPLOYEE QUALITIES
SCIENTIFIC
KNOWLEDGE
EXPERT
KNOWLEDGE
COMMUNICATION
STRATEGIC AGILITY
LEADERSHIP
RELATIONSHIP
BUILDING
TECHNICAL SKILLS
NETWORKING
INFLUENCING
MARKET
ACCESS
EMPLOYEE
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
Introduction
MARKET ACCESS DEPARTMENT BENCHMARKING
Market Access: Department models and structures 29www.ISRreports.com ©2015
Organizational Alignment
As the importance of the Market Access function grows, its position within the organization comes
under scrutiny� Several respondents mentioned that the group had been restructured or was in the
process of being restructured� There was also a seesaw noted within pharma companies between
centralization and decentralization with Market Access being no exception�
One respondent (Top 10 Pharma) mentioned that structural reorganization was not always conducted
in a way that considered the opinions of the team members within it, but was often the result of an
external evaluation from a consultancy organization�
WHERE GLOBAL MARKET ACCESS REPORTS
Interviewees were asked where in their organization the Market Access function reported, how
effective they consider the structure to be, and whether they feel Market Access employees have a
voice in the organization�
In the majority of companies, the global Market Access function reports into the Commercial arm
of the organization� While some respondents felt that this worked well as a reporting line, others
felt that Market Access would be better served in its own separate function� Three of the companies
interviewed (two Top 25 Pharma and one Top 10 Pharma) reported that the Market Access function
within their organization had a direct reporting line to the Executive leadership� The sentiment from
others was that Market Access structures are moving in this direction as the full value of the function
becomes acknowledged�
“We would probably benefit from a
voice in the executive levels. But, we
previously had a Senior Vice President
of Market Access person with a vision
that Market Access would educate the
organization so much that we would
become defunct. This didn’t work
out...”
(Top 10 Pharma)
“Market Access is limited because
we are considered almost as a global
marketing role when in reality Market
Access is more of a hybrid between
Medical, HEOR, and Commercial.
The organization doesn’t really know
where it should sit. I think it should be
a separate function reporting into the
head of Global Commercial.”
(Top 10 Pharma)
S A M P L E P A G E :
ORGANIZATIONAL ALIGNMENT
ISR interviewed 14 highly experienced decision-makers in the Market Access function
to gain insight from this report. In this section, interviewees were asked where in
their organization the Market Access function reported, how effective they consider
the structure to be, and whether they feel Market Access employees have a voice in
the organization. The report includes an analysis of ISR’s findings, as well as verbatim
responses from interviewees.
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
Introduction
MARKET ACCESS DEPARTMENT BENCHMARKING
Market Access: Department models and structures 31www.ISRreports.com ©2015
Outsourcing Behavior
All respondents reported outsourcing at least some Market Access activities� The scope and volume of
work varies according to the individual organization and the role within Market Access�
AMOUNT OF OUTSOURCING
Respondents were largely unable to estimate the internal versus external Market Access spend but
statements such as “we outsource a lot” and “we outsource all of the time” capture the sentiment of
the majority of respondents� One top 10 pharma company respondent estimated that over the last few
years approximately 70% of Market Access spend in their organization was external� Another estimated
external spend of between 30% and 50% of the budget�
Only one of the companies interviewed (Top 10 Pharma) said that most of the Market Access work
is done in-house in that organization� This company does use external vendors, but their activity is
limited to strategy work�
SERVICES OUTSOURCED
The activities outsourced range from tactical and logistical activities (organizing meetings,
presentations, and printing of materials), analytical work (modeling and programming), and time-
consuming technical documentation (global value dossiers and value propositions) through to strategy
and execution�
Activities most outsourced are those considered “heavy lifting” – those that take large amounts of time
which could be better utilized by the internal team�
“You’ll see more of the time-consuming work outsourced (analytical work, etc.),
and less strategic outsourcing” (Top 10 Pharma).
Type of Market Access Work Outsourced
PRICING
VALUE
DOSSIERS
HE
MODELING
PAYER
RESEARCH
INTERNAL
STRATEGY
MARKET
RESEARCH
(PRIMARY &
SECONDARY)
REAL
WORLD
EVIDENCE
GENERATION
LITERATURE
REVIEWS
REIMBURSEMENT
SERVICES
MARKETING
PRESENTATIONS
VALUE
PROPOSITIONSMEETINGS
S A M P L E P A G E :
OUTSOURCING BEHAVIOR
The activities outsourced range from tactical and logistical activities (organizing meetings,
presentations, and printing of materials), analytical work (modeling and programming),
and time consuming technical documentation (global value dossiers and value
propositions) through to strategy and execution.
More data is available in the report, which can be downloaded from www.ISRreports.com.
Introduction
SECTION NAME
Report title goes here 31www.ISRreports.com ©2015
Outsourcing Behavior
All respondents reported outsourcing at least some Market Access activities� The scope and volume of
work varies according to the individual organization and the role within Market Access�
AMOUNT OF OUTSOURCING
Respondents were largely unable to estimate the internal versus external Market Access spend but
statements such as “we outsource a lot” and “we outsource all of the time” capture the sentiment of
the majority of respondents� One top 10 pharma company respondent estimated that over the last few
years approximately 70% of Market Access spend in their organization was external� Another estimated
external spend of between 30% and 50% of the budget�
Only one of the companies interviewed (Top 10 Pharma) said that most of the Market Access work
is done in-house in that organization� This company does use external vendors, but their activity is
limited to strategy work�
SERVICES OUTSOURCED
The activities outsourced range from tactical and logistical activities (organizing meetings,
presentations, and printing of materials), analytical work (modeling and programming), and time-
consuming technical documentation (global value dossiers and value propositions) through to strategy
and execution�
Activities most outsourced are those considered “heavy lifting” – those that take large
amounts of time which could be better utilized by the internal team�
“You’ll see more of the time-consuming work outsourced (analytical work, etc.),
and less strategic outsourcing” (Top 10 Pharma).
Type of Market Access Work Outsourced
PRICING
VALUE
DOSSIERS
HE
MODELING
PAYER
RESEARCH
INTERNAL
STRATEGY
MARKET
RESEARCH
(PRIMARY & SECONDARY)
REAL
WORLD
EVIDENCE
GENERATION
LITERATURE
REVIEWS
REIMBURSEMENT
SERVICES
MARKETING
PRESENTATIONS
VALUE
PROPOSITIONSMEETINGS
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
ORDERING INFORMATION
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services
industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. 
 
For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at
www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
ABOUT INDUSTRY STANDARD RESEARCH
>> R E G I S T E R N O W
>>Receive $250 instant credit towards any ISR report
>>Earn 10% credit towards all future purchases
>>Receive advanced notifications on ISR’s latest reports and
free resources
SAVE ON THIS,
OR ANY ISR REPORT, BY
CREATING A
FREE ACCOUNT
For pricing and ordering information, visit ISR’s website:
www.isrreports.com/reports/market-access-department-models-and-structures/
Introduction
SMARTER QUESTIONS SMARTER ANSWERS
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 8
act with confidence
www.ISRreports.com ©2015 | Preview of: Epithelial Ovarian Cancer: Disease and Pipeline Analysis 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
The ISR Difference
Custom-quality syndicated market research
www.ISRreports.com
ISR's Reports
The Common
Syndicated Reportvs.
How confident are you?
vs.
DataCollection
ISR's proprietary data collection
tools and channels support fast,
high quality data collection
Struggle to recruit the right
targets and enough of them
vs.
SampleSizes
Robust sample sizes that
instill confidence
Often insufficient industry
representation that leaves you
defending results
vs.vs.
Research methods
Mostly primary
research;
always appropriate
for the topic
One size fits all;
usually publically
available data
vs.vs.
Respondents
Sophisticated screening
ensures genuine
decision-makers
Undisclosed
methodologies and
respondent demographics
vs.vs.
Analysts
Decades of experience
means more insights that are
immediately usable
Junior analysts capable of
reporting numbers

More Related Content

What's hot

Management Audit &Report
Management Audit &ReportManagement Audit &Report
Management Audit &Report
vishakeb
 
financial management project- ratio analysis
financial management project- ratio analysisfinancial management project- ratio analysis
financial management project- ratio analysis
yogita varma
 
Performance evaluation of mutual funds
Performance evaluation of mutual fundsPerformance evaluation of mutual funds
Performance evaluation of mutual funds
navnit1188
 
Scope of Pharmacy
Scope of PharmacyScope of Pharmacy
Scope of Pharmacy
Danish Paryanee
 
Management Audit
Management AuditManagement Audit
Management Audit
Augustin Bangalore
 
Audit assignment m.com part ii – semester iv
Audit assignment  m.com part ii – semester ivAudit assignment  m.com part ii – semester iv
Audit assignment m.com part ii – semester iv
Rutuja Chudnaik
 
PROCUREMENT
PROCUREMENTPROCUREMENT
PROCUREMENT
aishuanju
 
Unit 1. Introduction of audit.pptx
Unit 1. Introduction of audit.pptxUnit 1. Introduction of audit.pptx
Unit 1. Introduction of audit.pptx
MinalBhandari2
 
Be Appealing Revenue Cycle Management Series
Be Appealing Revenue Cycle Management SeriesBe Appealing Revenue Cycle Management Series
Be Appealing Revenue Cycle Management Series
CureMD
 
Limited Assurance Engagements for Practitioners
Limited Assurance Engagements for PractitionersLimited Assurance Engagements for Practitioners
Limited Assurance Engagements for Practitioners
International Federation of Accountants
 
Tms 1 slayt 2
Tms 1 slayt 2Tms 1 slayt 2
Tms 1 slayt 2
ÜMRAN BULUT
 
Revenue cycle management ppt ashish
Revenue cycle management ppt ashishRevenue cycle management ppt ashish
Revenue cycle management ppt ashish
Ashish Sinha
 
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
Dipendra Prasad Poudel
 
Rcm (Revenue Cycle Management)
Rcm (Revenue Cycle Management)Rcm (Revenue Cycle Management)
Rcm (Revenue Cycle Management)
Dan Wellisch
 
Pharmacy and therapeutic committee I.pptx
Pharmacy and therapeutic committee I.pptxPharmacy and therapeutic committee I.pptx
Pharmacy and therapeutic committee I.pptx
RAVINDRAMADHU
 
Inventory management rqm, eoq, im
Inventory management rqm, eoq, imInventory management rqm, eoq, im
Inventory management rqm, eoq, im
chiranjibi68
 

What's hot (19)

Management Audit &Report
Management Audit &ReportManagement Audit &Report
Management Audit &Report
 
financial management project- ratio analysis
financial management project- ratio analysisfinancial management project- ratio analysis
financial management project- ratio analysis
 
Performance evaluation of mutual funds
Performance evaluation of mutual fundsPerformance evaluation of mutual funds
Performance evaluation of mutual funds
 
Scope of Pharmacy
Scope of PharmacyScope of Pharmacy
Scope of Pharmacy
 
Audit reporting ISA 700
Audit reporting ISA 700Audit reporting ISA 700
Audit reporting ISA 700
 
Management Audit
Management AuditManagement Audit
Management Audit
 
Auditor's report
Auditor's reportAuditor's report
Auditor's report
 
Audit assignment m.com part ii – semester iv
Audit assignment  m.com part ii – semester ivAudit assignment  m.com part ii – semester iv
Audit assignment m.com part ii – semester iv
 
Debt equity ratio
Debt equity ratioDebt equity ratio
Debt equity ratio
 
PROCUREMENT
PROCUREMENTPROCUREMENT
PROCUREMENT
 
Unit 1. Introduction of audit.pptx
Unit 1. Introduction of audit.pptxUnit 1. Introduction of audit.pptx
Unit 1. Introduction of audit.pptx
 
Be Appealing Revenue Cycle Management Series
Be Appealing Revenue Cycle Management SeriesBe Appealing Revenue Cycle Management Series
Be Appealing Revenue Cycle Management Series
 
Limited Assurance Engagements for Practitioners
Limited Assurance Engagements for PractitionersLimited Assurance Engagements for Practitioners
Limited Assurance Engagements for Practitioners
 
Tms 1 slayt 2
Tms 1 slayt 2Tms 1 slayt 2
Tms 1 slayt 2
 
Revenue cycle management ppt ashish
Revenue cycle management ppt ashishRevenue cycle management ppt ashish
Revenue cycle management ppt ashish
 
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
SA 706," Emphasis of Matter Paragraph and Other Matter Paragraph in the Indep...
 
Rcm (Revenue Cycle Management)
Rcm (Revenue Cycle Management)Rcm (Revenue Cycle Management)
Rcm (Revenue Cycle Management)
 
Pharmacy and therapeutic committee I.pptx
Pharmacy and therapeutic committee I.pptxPharmacy and therapeutic committee I.pptx
Pharmacy and therapeutic committee I.pptx
 
Inventory management rqm, eoq, im
Inventory management rqm, eoq, imInventory management rqm, eoq, im
Inventory management rqm, eoq, im
 

Viewers also liked

Insights to Managed Care Contracting
Insights to Managed Care ContractingInsights to Managed Care Contracting
Insights to Managed Care Contracting
PALIO
 
Provider Network Development
Provider Network DevelopmentProvider Network Development
Provider Network Development
Allen Spath
 
Managed care contracting 101
Managed care contracting 101Managed care contracting 101
Managed care contracting 101Allen Spath
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectivePM Society
 
Managed Care Contracting Strategy
Managed Care Contracting StrategyManaged Care Contracting Strategy
Managed Care Contracting Strategy
chriskalkhof
 

Viewers also liked (6)

Insights to Managed Care Contracting
Insights to Managed Care ContractingInsights to Managed Care Contracting
Insights to Managed Care Contracting
 
Provider Network Development
Provider Network DevelopmentProvider Network Development
Provider Network Development
 
Managed care contracting 101
Managed care contracting 101Managed care contracting 101
Managed care contracting 101
 
Market Access
Market AccessMarket Access
Market Access
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
 
Managed Care Contracting Strategy
Managed Care Contracting StrategyManaged Care Contracting Strategy
Managed Care Contracting Strategy
 

Similar to Market Access: department models and structures

Human Capital Management Market by Solution
Human Capital Management Market by SolutionHuman Capital Management Market by Solution
Human Capital Management Market by Solution
MarketResearch.com
 
Organizational Diagnostic for Market Facilitation
Organizational Diagnostic for Market FacilitationOrganizational Diagnostic for Market Facilitation
Organizational Diagnostic for Market Facilitation
Market Development Training
 
Business Strategy LO3.PPTX
Business Strategy LO3.PPTXBusiness Strategy LO3.PPTX
Business Strategy LO3.PPTX
RuhDil
 
Building The Outer Structure
Building The Outer StructureBuilding The Outer Structure
Building The Outer Structure
Rufus Simmons III,MBA
 
Group 5 presentation strategic management
Group 5 presentation strategic managementGroup 5 presentation strategic management
Group 5 presentation strategic management
Michael Alonzo
 
Before 1900, despite its weaknesses in effective management of worke.pdf
Before 1900, despite its weaknesses in effective management of worke.pdfBefore 1900, despite its weaknesses in effective management of worke.pdf
Before 1900, despite its weaknesses in effective management of worke.pdf
arishaenterprises12
 
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
Value4Brand
 
Benchmarking Culture
Benchmarking CultureBenchmarking Culture
Benchmarking Culture
MarketCulture
 
Building a Perform Culture
Building a Perform CultureBuilding a Perform Culture
Building a Perform Culture
Charles Bedard
 
L 8 growth accelerators, vrio analysis
L 8 growth accelerators, vrio analysisL 8 growth accelerators, vrio analysis
L 8 growth accelerators, vrio analysis
Sudhir Upadhyay
 
Feedback from peersThanks so much for your response. Very wel
Feedback from peersThanks so much for your response. Very welFeedback from peersThanks so much for your response. Very wel
Feedback from peersThanks so much for your response. Very wel
ChereCheek752
 
Advertising and Campaign planning
Advertising and Campaign planningAdvertising and Campaign planning
Advertising and Campaign planning
Dr. Anupama S. Kotur (Kaddi)
 
Fitness App Market.ppt
Fitness App Market.pptFitness App Market.ppt
Fitness App Market.ppt
Oliviadsouza11
 
Fitness App Market.ppt
Fitness App Market.pptFitness App Market.ppt
Fitness App Market.ppt
Oliviadsouza11
 
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACH
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACHBUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACH
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACHDr. PRINCE YEAKEHSON
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
Industry Standard Research
 
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
AndreasPrasetia1
 

Similar to Market Access: department models and structures (20)

Human Capital Management Market by Solution
Human Capital Management Market by SolutionHuman Capital Management Market by Solution
Human Capital Management Market by Solution
 
Organizational Diagnostic for Market Facilitation
Organizational Diagnostic for Market FacilitationOrganizational Diagnostic for Market Facilitation
Organizational Diagnostic for Market Facilitation
 
Material 1 - Blog - Learn, do and growth
Material 1 - Blog - Learn, do and growthMaterial 1 - Blog - Learn, do and growth
Material 1 - Blog - Learn, do and growth
 
Business Strategy LO3.PPTX
Business Strategy LO3.PPTXBusiness Strategy LO3.PPTX
Business Strategy LO3.PPTX
 
Strategy
StrategyStrategy
Strategy
 
Building The Outer Structure
Building The Outer StructureBuilding The Outer Structure
Building The Outer Structure
 
Group 5 presentation strategic management
Group 5 presentation strategic managementGroup 5 presentation strategic management
Group 5 presentation strategic management
 
Before 1900, despite its weaknesses in effective management of worke.pdf
Before 1900, despite its weaknesses in effective management of worke.pdfBefore 1900, despite its weaknesses in effective management of worke.pdf
Before 1900, despite its weaknesses in effective management of worke.pdf
 
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
Know Future Outlook of Enterprise Reputation Management Market Key Players Ne...
 
Benchmarking Culture
Benchmarking CultureBenchmarking Culture
Benchmarking Culture
 
Building a Perform Culture
Building a Perform CultureBuilding a Perform Culture
Building a Perform Culture
 
L 8 growth accelerators, vrio analysis
L 8 growth accelerators, vrio analysisL 8 growth accelerators, vrio analysis
L 8 growth accelerators, vrio analysis
 
Market entry strategy
Market entry strategyMarket entry strategy
Market entry strategy
 
Feedback from peersThanks so much for your response. Very wel
Feedback from peersThanks so much for your response. Very welFeedback from peersThanks so much for your response. Very wel
Feedback from peersThanks so much for your response. Very wel
 
Advertising and Campaign planning
Advertising and Campaign planningAdvertising and Campaign planning
Advertising and Campaign planning
 
Fitness App Market.ppt
Fitness App Market.pptFitness App Market.ppt
Fitness App Market.ppt
 
Fitness App Market.ppt
Fitness App Market.pptFitness App Market.ppt
Fitness App Market.ppt
 
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACH
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACHBUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACH
BUSINESS INTEGRATION AND EVALUATION-A GLOBAL APPROACH
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
 
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
06. chapter 5 dzulfikar prasetya (55120110154) & jhonny s.m siburian (551...
 

More from Industry Standard Research

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Industry Standard Research
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient Recruitment
Industry Standard Research
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Industry Standard Research
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
Industry Standard Research
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Industry Standard Research
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
Industry Standard Research
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
Industry Standard Research
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
Industry Standard Research
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
Industry Standard Research
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
Industry Standard Research
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
Industry Standard Research
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Industry Standard Research
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
Industry Standard Research
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
Industry Standard Research
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
Industry Standard Research
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
Industry Standard Research
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Industry Standard Research
 
Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)  Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)
Industry Standard Research
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?
Industry Standard Research
 

More from Industry Standard Research (20)

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient Recruitment
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
 
Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
 
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Orphan Drug 101
 
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
 
Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)  Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?
 

Recently uploaded

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 

Market Access: department models and structures

  • 1. MARKET ACCESS: DEPARTMENT MODELS AND STRUCTURES N O V E M B E R , 2 0 1 5 P R E V I E W O F marketaccess
  • 2. REPORT OVERVIEW WHAT YOU WILL LEARN How you can use this report ISR interviewed 14 highly experienced decision- makers to better understand the Market Access function. These professionals shared their perspectives on a range of topics related to the Market Access function, including the role of Market Access within their organizations, the structure of the Market Access function, and the key challenges faced by Market Access. Where possible, ISR also collected information on departmental headcounts, budgets, and outsourcing volume. 54 PAGES 19 POTENTIAL BEST PRACTICES CAPTURED INTERVIEWEE TITLES MAJOR SECTIONS: 1. Introduction 2. Market Access Employees 3. Market Access Goals and Priorities 4. Market Access Structure 5. Organizational Alignment 6. Outsourcing Behavior 7. Market Access Budget 8. Challenges 9. Future Predictions 10. Best Practices and Recommendations • Market Access department operations and structuring, including: • Division of work for both global and regional Market Access • Common department structure and unique department structures within companies • Organizational alignment and comparison of Market Access placement • Outsourcing behavior: services outsourced, vendor selection, reasons for outsourcing • Future predictions for the department • Sources of Market Access budget, including factors that impact budget and sources of funding • Market Access goals and priorities, including strategies for overcoming challenges and predictions for future changes • Best practices for: Market Access budget and challenges, timing of Market Access involvement, outsourcing behaviors, department structure and function • Determine where your company’s approach to Market Access may be different from a typical industry approach and the benefits and drawbacks that may result. • Gather information on unique Market Access structures or philosophies employed by other organizations to provide a new perspective from which to consider your company’s philosophies. • Compare your company’s approach to the size the Market Access function and budget against those of other companies. Introduction SMARTER QUESTIONS SMARTER ANSWERS • Head, Global Market Access • Head, Global Pricing and Market Access • Senior Director, Global Market Access • Senior Director, Market Access • Director, Global Market Access • Director, Market Access • Director, Market Access and Health Economics • Director, Market Access Strategy • Director, Pricing and Reimbursement • Associate Director, Global Pricing and Market Access • Associate Director, Reimbursement and Market Access • Senior Manager, Market Access D A T A C O L L E C T I O N I N Q 3 , 2 0 1 5 6 0 - M I N U T E T E L E P H O N E I N T E R V I E W S 1 4 E X P E R I E N C E D M A R K E T A C C E S S P R O F E S S I O N A L S
  • 3. Introduction SMARTER QUESTIONS SMARTER ANSWERS TABLE OF CONTENTS To view the Table of Contents, download the full preview from: www.isrreports.com/reports/market-access-department-models-and-structures/
  • 4. Introduction SMARTER QUESTIONS SMARTER ANSWERS UNDERSTANDING THE MARKET ACCESS FUNCTION Market Access: Department models and structures 12www.ISRreports.com ©2015 Though the desired skillsets vary according to the specific role, interviewees described a number of qualities that are critical to success in any Market Access role� Communication is considered one of the core skills required for success in Market Access� The role requires interaction and engagement with a range of colleagues internally as well as with reimbursement and payer bodies externally� The global Market Access role was described as a bridge between the Clinical Development and Commercial functions� Influencing skills are also critical� Interviewees commented that the role could be viewed as “the harbinger of bad news” within a multidisciplinary team as their input can be seen to increase workload and expense of clinical trials and commercialization plans� It is therefore important to be able to influence decision-making in a way that is considered thoughtful, incisive, and from a position of knowledge and experience. Networking skills are essential as the role requires an “ability to reach across the aisle and work with all of the different functions� This requires an individual who can influence without a direct reporting line, engage, and align” (Top 10 Pharma)� The highly matrixed environment of Market Access means that there are many reporting lines and thereby many different priorities which must be successfully managed to meet timelines� For local Market Access roles, networking is required to maintain contacts within other countries as well as their own regions. OYEE QUALITIES SCIENTIFIC KNOWLEDGE EXPERT KNOWLEDGE COMMUNICATION STRATEGIC AGILITY LEADERSHIP RELATIONSHIP BUILDING TECHNICAL SKILLS NETWORKING INFLUENCING MARKET ACCESS EMPLOYEE S A M P L E P A G E : MARKET ACCESS EMPLOYEE QUALITIES Communication is considered one of the core skills required for success in Market Access. The role requires interaction and engagement with a range of colleagues internally as well as with reimbursement and payer bodies externally. The global Market Access role was described as a bridge between the Clinical Development and Commercial functions. C L O S E R L O O K >>This chart shows a number of qualities that are necessary to be successful in the Market Access role. Introduction SECTION NAME Though the desired skillsets vary according to the specific role, interviewees described a number of qualities that are critical to success in any Market Access role� EMPLOYEE QUALITIES SCIENTIFIC KNOWLEDGE EXPERT KNOWLEDGE COMMUNICATION STRATEGIC AGILITY LEADERSHIP RELATIONSHIP BUILDING TECHNICAL SKILLS NETWORKING INFLUENCING MARKET ACCESS EMPLOYEE
  • 5. Introduction SMARTER QUESTIONS SMARTER ANSWERS Introduction MARKET ACCESS DEPARTMENT BENCHMARKING Market Access: Department models and structures 29www.ISRreports.com ©2015 Organizational Alignment As the importance of the Market Access function grows, its position within the organization comes under scrutiny� Several respondents mentioned that the group had been restructured or was in the process of being restructured� There was also a seesaw noted within pharma companies between centralization and decentralization with Market Access being no exception� One respondent (Top 10 Pharma) mentioned that structural reorganization was not always conducted in a way that considered the opinions of the team members within it, but was often the result of an external evaluation from a consultancy organization� WHERE GLOBAL MARKET ACCESS REPORTS Interviewees were asked where in their organization the Market Access function reported, how effective they consider the structure to be, and whether they feel Market Access employees have a voice in the organization� In the majority of companies, the global Market Access function reports into the Commercial arm of the organization� While some respondents felt that this worked well as a reporting line, others felt that Market Access would be better served in its own separate function� Three of the companies interviewed (two Top 25 Pharma and one Top 10 Pharma) reported that the Market Access function within their organization had a direct reporting line to the Executive leadership� The sentiment from others was that Market Access structures are moving in this direction as the full value of the function becomes acknowledged� “We would probably benefit from a voice in the executive levels. But, we previously had a Senior Vice President of Market Access person with a vision that Market Access would educate the organization so much that we would become defunct. This didn’t work out...” (Top 10 Pharma) “Market Access is limited because we are considered almost as a global marketing role when in reality Market Access is more of a hybrid between Medical, HEOR, and Commercial. The organization doesn’t really know where it should sit. I think it should be a separate function reporting into the head of Global Commercial.” (Top 10 Pharma) S A M P L E P A G E : ORGANIZATIONAL ALIGNMENT ISR interviewed 14 highly experienced decision-makers in the Market Access function to gain insight from this report. In this section, interviewees were asked where in their organization the Market Access function reported, how effective they consider the structure to be, and whether they feel Market Access employees have a voice in the organization. The report includes an analysis of ISR’s findings, as well as verbatim responses from interviewees.
  • 6. Introduction SMARTER QUESTIONS SMARTER ANSWERS Introduction MARKET ACCESS DEPARTMENT BENCHMARKING Market Access: Department models and structures 31www.ISRreports.com ©2015 Outsourcing Behavior All respondents reported outsourcing at least some Market Access activities� The scope and volume of work varies according to the individual organization and the role within Market Access� AMOUNT OF OUTSOURCING Respondents were largely unable to estimate the internal versus external Market Access spend but statements such as “we outsource a lot” and “we outsource all of the time” capture the sentiment of the majority of respondents� One top 10 pharma company respondent estimated that over the last few years approximately 70% of Market Access spend in their organization was external� Another estimated external spend of between 30% and 50% of the budget� Only one of the companies interviewed (Top 10 Pharma) said that most of the Market Access work is done in-house in that organization� This company does use external vendors, but their activity is limited to strategy work� SERVICES OUTSOURCED The activities outsourced range from tactical and logistical activities (organizing meetings, presentations, and printing of materials), analytical work (modeling and programming), and time- consuming technical documentation (global value dossiers and value propositions) through to strategy and execution� Activities most outsourced are those considered “heavy lifting” – those that take large amounts of time which could be better utilized by the internal team� “You’ll see more of the time-consuming work outsourced (analytical work, etc.), and less strategic outsourcing” (Top 10 Pharma). Type of Market Access Work Outsourced PRICING VALUE DOSSIERS HE MODELING PAYER RESEARCH INTERNAL STRATEGY MARKET RESEARCH (PRIMARY & SECONDARY) REAL WORLD EVIDENCE GENERATION LITERATURE REVIEWS REIMBURSEMENT SERVICES MARKETING PRESENTATIONS VALUE PROPOSITIONSMEETINGS S A M P L E P A G E : OUTSOURCING BEHAVIOR The activities outsourced range from tactical and logistical activities (organizing meetings, presentations, and printing of materials), analytical work (modeling and programming), and time consuming technical documentation (global value dossiers and value propositions) through to strategy and execution. More data is available in the report, which can be downloaded from www.ISRreports.com. Introduction SECTION NAME Report title goes here 31www.ISRreports.com ©2015 Outsourcing Behavior All respondents reported outsourcing at least some Market Access activities� The scope and volume of work varies according to the individual organization and the role within Market Access� AMOUNT OF OUTSOURCING Respondents were largely unable to estimate the internal versus external Market Access spend but statements such as “we outsource a lot” and “we outsource all of the time” capture the sentiment of the majority of respondents� One top 10 pharma company respondent estimated that over the last few years approximately 70% of Market Access spend in their organization was external� Another estimated external spend of between 30% and 50% of the budget� Only one of the companies interviewed (Top 10 Pharma) said that most of the Market Access work is done in-house in that organization� This company does use external vendors, but their activity is limited to strategy work� SERVICES OUTSOURCED The activities outsourced range from tactical and logistical activities (organizing meetings, presentations, and printing of materials), analytical work (modeling and programming), and time- consuming technical documentation (global value dossiers and value propositions) through to strategy and execution� Activities most outsourced are those considered “heavy lifting” – those that take large amounts of time which could be better utilized by the internal team� “You’ll see more of the time-consuming work outsourced (analytical work, etc.), and less strategic outsourcing” (Top 10 Pharma). Type of Market Access Work Outsourced PRICING VALUE DOSSIERS HE MODELING PAYER RESEARCH INTERNAL STRATEGY MARKET RESEARCH (PRIMARY & SECONDARY) REAL WORLD EVIDENCE GENERATION LITERATURE REVIEWS REIMBURSEMENT SERVICES MARKETING PRESENTATIONS VALUE PROPOSITIONSMEETINGS
  • 7. Introduction SMARTER QUESTIONS SMARTER ANSWERS ORDERING INFORMATION Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.    For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports. ABOUT INDUSTRY STANDARD RESEARCH >> R E G I S T E R N O W >>Receive $250 instant credit towards any ISR report >>Earn 10% credit towards all future purchases >>Receive advanced notifications on ISR’s latest reports and free resources SAVE ON THIS, OR ANY ISR REPORT, BY CREATING A FREE ACCOUNT For pricing and ordering information, visit ISR’s website: www.isrreports.com/reports/market-access-department-models-and-structures/
  • 8. Introduction SMARTER QUESTIONS SMARTER ANSWERS www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 8 act with confidence www.ISRreports.com ©2015 | Preview of: Epithelial Ovarian Cancer: Disease and Pipeline Analysis 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence The ISR Difference Custom-quality syndicated market research www.ISRreports.com ISR's Reports The Common Syndicated Reportvs. How confident are you? vs. DataCollection ISR's proprietary data collection tools and channels support fast, high quality data collection Struggle to recruit the right targets and enough of them vs. SampleSizes Robust sample sizes that instill confidence Often insufficient industry representation that leaves you defending results vs.vs. Research methods Mostly primary research; always appropriate for the topic One size fits all; usually publically available data vs.vs. Respondents Sophisticated screening ensures genuine decision-makers Undisclosed methodologies and respondent demographics vs.vs. Analysts Decades of experience means more insights that are immediately usable Junior analysts capable of reporting numbers